Art

J-GLOBAL ID：202102248681324152   Reference number：21A0137873

Guidelines on the Clinical Evaluation of Medicinal Products for Treatment of Dyslipidemia

脂質異常症の治療に対する医薬品の臨床評価に関するガイドライン

Author (22)： Yamashita Shizuya (Rinku General Medical Center) ,  Masuda Daisaku (Rinku General Medical Center) ,  Akishita Masahiro (Department of Geriatric Medicine, Graduate School of Medicine, the University of Tokyo) ,  Arai Hidenori (National Center for Geriatrics and Gerontology) ,  Asada Yujiro (Department of Pathology, Faculty of Medicine, University of Miyazaki) ,  Dobashi Kazushige (Department of Pediatrics, Enzan Citizen Hospital) ,  Egashira Kensuke (Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical Sciences) ,  Harada-Shiba Mariko (Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute) ,  Hirata Kenichi (Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine) ,  Ishibashi Shun (Division of Endocrinology and Metabolism, Department of Medicine, Jichi Medical University) ,  Kajinami Kouji (Department of Cardiology, Kanazawa Medical University) ,  Kinoshita Makoto (Toray Industries, Inc.) ,  Kozaki Koichi (Department of Geriatric Medicine, Kyorin University School of Medicine) ,  Kuzuya Masafumi (Department of Community Healthcare and Geriatrics, Nagoya University Graduate School of Medicine) ,  Ogura Masatsune (Department of Molecular Innovation in Lipidology, National Cerebral and Cardiovascular Center Research Institute) ,  Okamura Tomonori (Preventive Medicine and Public Health, Keio University School of Medicine) ,  Sato Kayoko (Department of Cardiology, Tokyo Women’s Medical University) ,  Shimano Hitoshi (Department of Internal Medicine (Endocrinology and Metabolism), Faculty of Medicine, University of Tsukuba) ,  Tsukamoto Kazuhisa (Department of Internal Medicine, Teikyo University School of Medicine) ,  Yokode Masayuki (Department of Clinical Innovative Medicine, Kyoto University Graduate School of Medicine) ,  Yokote Koutaro (Department of Endocrinology, Hematology and Gerontology, Chiba University Graduate School of Medicin) ,  Yoshida Masayuki (Division of Medical Genetics, Medical Hospital of Tokyo Medical and Dental University)
Material： Journal of Atherosclerosis and Thrombosis (Web)  (J Atheroscler Thromb (Web))
Volume： 27  Issue： 11  Page： 1246-1254(J-STAGE)  Publication year： 2020 
JST Material Number： U0153A  ISSN： 1880-3873  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： Effectiveness assessment

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0137873&from=J-GLOBAL&jstjournalNo=U0153A") }}

Author keywords (6)： Guidelines ,  Clinical Evaluation ,  Medicinal Products ,  Treatment of Dyslipidemia ,  LDL-C ,  Japanese

JST classification (3)： Metabolic diseases,nutritional diseases in general.  (GD05010J) ,  Research and development  (GA01030U) ,  Pharmaceutical affairs,pharmaceutical practice  (GU01020R)

Reference (9)：

• 1) Kinoshita M, Yokote K, Arai H, Iida M, Ishigaki Y, Ishibashi S, Seiji Umemoto S, Egusa G, Ohmura H, Okamura T, Kihara S, Koba S, Saito I, Shoji T, Daida H, Tsukamoto K, Deguchi J, Dohi S, Dobashi K, Hamaguchi H, Hara M, Hiro T, Biro S, Fujioka Y, Maruyama C, Miyamoto Y, Murakami Y, Yokode M, Yoshida H, Rakugi H, Wakatsuki A, Yamashita S, Committee for Epidemiology and Clinical Management of Atherosclerosis: Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017. J Atheroscler Thromb, 2018; 25: 846-984
• 2) Notification No.796 issued by Pharmaceutical and Medical Safety Bureau, Ministry of Health and Welfare. 2001. (in Japanese)
• 3) Guideline on drug interaction for drug development and appropriate provision of information. 2018. (in Japanese, MHLW, https://www.pmda.go.jp/rs-std-jp/standards-development/guidance-guideline/0001.html)
• 4) Kajinami K, Tsukamoto K, Koba S, Inoue I, Yamakawa M, Suzuki S, Hamano T, Saito H, Saito Y, Masuda S, Nakayama T, Okamura T, Yamashita S, Kagawa T, Kaneyama J, Kuriyama A, Tanaka R, Hirata A, Statin Intolerance Clinical Guide Working Group; The Japan Society of Hepatology, Japanese Society of Neurology, Japan Atherosclerosis Society, The Japanese Society for the Study of Xenobiotics: Statin intolerance clinical guide 2018. J Atheroscler Thromb, 2020; 27: 375-396
• 5) Satake S, Arai H: Chapter 1 Frailty: Definition, diagnosis, epidemiology. Geriatr Gerontol Int, 2020 Feb; 20 Suppl 1: 7-13

Terms in the title (5)： 脂質異常症 ,  治療 ,  医薬品 ,  臨床評価 ,  ガイドライン